Variation in Modifies Risk of Neonatal Intestinal Obstruction in Cystic Fibrosis
Meconium ileus (MI), a life-threatening intestinal obstruction due to meconium with abnormal protein content, occurs in approximately 15 percent of neonates with cystic fibrosis (CF). Analysis of twins with CF demonstrates that MI is a highly heritable trait, indicating that genetic modifiers are largely responsible for this complication. Here, we performed regional family-based association analysis of a locus that had previously been linked to MI and found that SNP haplotypes 5′ to and within the MSRA gene were associated with MI (P = 1.99×10−5 to 1.08×10−6; Bonferroni P = 0.057 to 3.1×10−3). The haplotype with the lowest P value showed association with MI in an independent sample of 1,335 unrelated CF patients (OR = 0.72, 95% CI [0.53–0.98], P = 0.04). Intestinal obstruction at the time of weaning was decreased in CF mice with Msra null alleles compared to those with wild-type Msra resulting in significant improvement in survival (P = 1.2×10−4). Similar levels of goblet cell hyperplasia were observed in the ilea of the Cftr−/− and Cftr−/−Msra−/− mice. Modulation of MSRA, an antioxidant shown to preserve the activity of enzymes, may influence proteolysis in the developing intestine of the CF fetus, thereby altering the incidence of obstruction in the newborn period. Identification of MSRA as a modifier of MI provides new insight into the biologic mechanism of neonatal intestinal obstruction caused by loss of CFTR function.
Vyšlo v časopise:
Variation in Modifies Risk of Neonatal Intestinal Obstruction in Cystic Fibrosis. PLoS Genet 8(3): e32767. doi:10.1371/journal.pgen.1002580
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002580
Souhrn
Meconium ileus (MI), a life-threatening intestinal obstruction due to meconium with abnormal protein content, occurs in approximately 15 percent of neonates with cystic fibrosis (CF). Analysis of twins with CF demonstrates that MI is a highly heritable trait, indicating that genetic modifiers are largely responsible for this complication. Here, we performed regional family-based association analysis of a locus that had previously been linked to MI and found that SNP haplotypes 5′ to and within the MSRA gene were associated with MI (P = 1.99×10−5 to 1.08×10−6; Bonferroni P = 0.057 to 3.1×10−3). The haplotype with the lowest P value showed association with MI in an independent sample of 1,335 unrelated CF patients (OR = 0.72, 95% CI [0.53–0.98], P = 0.04). Intestinal obstruction at the time of weaning was decreased in CF mice with Msra null alleles compared to those with wild-type Msra resulting in significant improvement in survival (P = 1.2×10−4). Similar levels of goblet cell hyperplasia were observed in the ilea of the Cftr−/− and Cftr−/−Msra−/− mice. Modulation of MSRA, an antioxidant shown to preserve the activity of enzymes, may influence proteolysis in the developing intestine of the CF fetus, thereby altering the incidence of obstruction in the newborn period. Identification of MSRA as a modifier of MI provides new insight into the biologic mechanism of neonatal intestinal obstruction caused by loss of CFTR function.
Zdroje
1. WelshMJRamseyBWAccursoFJCuttingGR 2001 Cystic Fibrosis. ScriverCRBeaudetALValleDSlyWS The Metabolic and Molecular Bases of Inherited Disease New York McGraw-Hill, Inc 5121 5188
2. SchuttWHIslesTE 1968 Protein in meconium from meconium ileus. Arch Dis Child 43 178 181
3. BrockDJBarronL 1986 Biochemical analysis of meconium in fetuses presumed to have cystic fibrosis. Prenat Diagn 6 291 298
4. HsiehMCBerryHK 1988 Protease inhibitor and defective proteolysis in cystic fibrosis. Dig Dis Sci 33 282 288
5. EvansAKFitzgeraldDAMcKayKO 2001 The impact of meconium ileus on the clinical course of children with cystic fibrosis. Eur Respir J 18 784 789
6. LaiHJChengYChoHKosorokMRFarrellPM 2004 Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis. Am J Epidemiol 159 537 546
7. KapplerMFeilckeMSchroterCKraxnerAGrieseM 2009 Long-term pulmonary outcome after meconium ileus in cystic fibrosis. Pediatr Pulmonol 44 1201 1206
8. DonnisonABShwachmanHGrossRE 1966 A review of 164 children with meconium ileus seen at the Children's Hospital Medical Center, Boston. Pediatrics 37 833 850
9. AllanJRRobbieMPhelanPDDanksDM 1981 Familial occurence of meconium ileus. Eur J Ped 135 291 292
10. KeremECoreyMKeremB-SDuriePTsuiLC 1989 Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J Pediatr 114 767 773
11. PicardEAviramMYahavYRivlinJBlauH 2004 Familial concordance of phenotype and microbial variation among siblings with CF. Pediatr Pulmonol 38 292 297
12. BlackmanSMDeering-BroseRMcWilliamsRNaughtonKColemanB 2006 Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis. Gastroenterology 131 1030 1039
13. KeremBRommensJMBuchananJAMarkiewiczDCoxTK 1989 Identification of the cystic fibrosis gene: genetic analysis. Science 245 1073 1080
14. KristidisPBozonDCoreyMMarkiewiczDRommensJ 1992 Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 50 1178 1184
15. HamoshAKingTMRosensteinBJCoreyMLevisonH 1992 Cystic fibrosis patients bearing the common missense mutation Gly->Asp at codon 551 and the deltaF508 are indistinguishable from deltaF508 homozygotes except for decreased risk of meconium ileus. Am J Hum Genet 51 245 250
16. FeingoldJGuilloud-BatailleM 1999 Genetic comparisons of patients with cystic fibrosis with or without meconium ileus. Clinical Centers of the French CF Registry. Ann Genet 42 147 150
17. SnouwaertJNBrigmanKKLatourAMMaloufNNBoucherRC 1992 An animal model for cystic fibrosis made by gene targeting. Science 257 1083 1088
18. RatcliffREvansMJCuthbertAWMacVinishLJFosterD 1993 Production of a severe cystic fibrosis mutation in mice by gene targeting. Nat Genet 4 35 41
19. RozmahelRWilschanskiMMatinAPlyteSOliverM 1996 Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nature Genet 12 280 287
20. HouwenRHvan der DoefHPSermetIMunckAHauserB 2010 Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS. J Pediatr Gastroenterol Nutr 50 38 42
21. ColomboCEllemunterHHouwenRMunckATaylorC 2011 Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients. J Cyst Fibros 10 Suppl 2 S24 S28
22. GrubbBRBoucherRC 1999 Pathophysiology of gene-targeted mouse models for cystic fibrosis. APS Conf 79 S193 S214
23. DorinJRDickinsonPAltonEWFWSmithSNGeddesDM 1992 Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature 359 211 215
24. ColledgeWHAbellaBSSouthernKWRatcliffRJiangC 1995 Generation and characterization of a deltaF508 cystic fibrosis mouse model. Nature Genet 10 445 452
25. DorinJRStevensonBJFlemingSAltonEWDickinsonP 1994 Long-term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild-type CFTR gene expression. Mamm Genome 5 465 472
26. van DoorninckJHFrenchPJVerbeekEPetersRHPCMorreauH 1995 A mouse model for the cystic fibrosis deltaF508 mutation. EMBO J 14 4403 4411
27. DelaneySJAltonESmithSLunnDFarleyD 1996 Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations. EMBO J 15 955 963
28. DickinsonPKimberWLKilanowskiFMWebbSStevensonBJ 2000 Enhancing the efficiency of introducing precise mutations into the mouse genome by hit and run gene targeting. Transgenic Res 9 55 66
29. BradfordEMSartorMAGawenisLRClarkeLLShullGE 2009 Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice. Am J Physiol Gastrointest Liver Physiol 296 G886 G898
30. ParmleyRRGendlerSJ 1998 Cystic fibrosis mice lacking Muc1 have reduced amounts of intestinal mucus. J Clin Invest 102 1798 1806
31. YoungFDNewbiggingSChoiCKeetMKentG 2007 Amelioration of cystic fibrosis intestinal mucous disease in mice by restoration of mCLCA3. Gastroenterology 133 1928 1937
32. SunXSuiHFisherJTYanZLiuX 2010 Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J Clin Invest 120 3149 3160
33. MeyerholzDKStoltzDAPezzuloAAWelshMJ 2010 Pathology of gastrointestinal organs in a porcine model of cystic fibrosis. Am J Pathol 176 1377 1389
34. WrightFAStrugLJDoshiVKCommanderCWBlackmanSM 2011 Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nature Genet 43 539 546
35. LangeCLairdNM 2002 On a general class of conditional tests for family-based association studies in genetics: the asymptotic distribution, the conditional power, and optimality considerations. Genet Epidemiol 23 165 180
36. BremerLABlackmanSMVanscoyLLMcDougalKEBowersA 2008 Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis. Hum Mol Genet 17 2228 2237
37. GreeneCSPenrodNMWilliamsSMMooreJH 2009 Failure to replicate a genetic association may provide important clues about genetic architecture. PLoS ONE 4 e5639 doi:10.1371/journal.pone.0005639
38. GalarneauGPalmerCDSankaranVGOrkinSHHirschhornJN 2010 Fine-mapping at three loci known to affect fetal hemoglobin levels explains addtional genetic variation. Nature Genet 42 1049 1051
39. WoodARHernandezDGNallsMAYaghootkarHGibbsJR 2011 Allelic heterogeneity and more detailed analyses of known loci explain additional phenotypic variation and reveal complex patterns of association. Hum Mol Genet 20 4082 4092
40. DorfmanRLiWSunLLinFWangY 2009 Modifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping results. Hum Genet 126 763 778
41. WatsonMSCuttingGRDesnickRJDriscollDAKlingerK 2004 Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 6 387 391
42. van HouwelingenHCArendsLRStijnenT 2002 Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21 589 624
43. WilkeMBuijs-OffermanRMAarbiouJColledgeWHSheppardDN 2011 Mouse models of cystic fibrosis: Phenotypic analysis and research applications. Journal of Cystic Fibrosis 10 S152 S171
44. Van HeeckerenAMSchluchterMDDrummMLDavisPB 2004 Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 287 L944 L952
45. SheppardDNRichDPOstedgaardLSGregoryRJSmithAE 1993 Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties. Nature 362 160 164
46. CarrollTPMcIntoshIEganMEZeitlinPLCuttingGR 1994 Transmembrane mutations alter the channels characteristics of the cystic fibrosis transmembrane conductance regulator expressed in Xenopus oocytes. Cell Physiol Biochem 4 10 18
47. The Cystic Fibrosis Genotype-Phenotype Consortium 1993 Correlation between Genotype and Phenotype in Patients with Cystic Fibrosis. N Engl J Med 329 1308
48. HodgesCACottonCUPalmertMRDrummML 2008 Generation of a conditional null allele for Cftr in mice. Genesis 46 546 552
49. ZielenskiJCoreyMRozmahelRMarkiewiczDAznarezI 1999 Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nature Genet 22 128 129
50. NorkinaODe LisleRC 2005 Potential genetic modifiers of the cystic fibrosis intestinal inflammatory phenotype on mouse chromosomes 1, 9, and 10. BMC Genet 6 29
51. MoskovitzJBar-NoySWilliamsWMRequenaJBerlettBS 2001 Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci U S A 98 12920 12925
52. van der DoefHPSliekerMGStaabDAlizadehBZSeiaM 2010 Association of the CLCA1 p.S357N variant with meconium ileus in European patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 50 347 349
53. BerschneiderHMKnowlesMRAzizkhanRGBoucherRCTobeyNA 1988 Altered intestinal chloride transport in cystic fibrosis. FASEB J 2 2625 2629
54. TaylorCJBaxterPSHardcastleJHardcastlePT 1988 Failure to induce secretion in jejunal biopsies from children with cystic fibrosis. Gut 29 957 962
55. GreenMNClarkeJTShwachmanH 1958 Studies in cystic fibrosis of the pancreas; protein pattern in meconium ileus. Pediatrics 21 635 641
56. O'NealWKHastyPMcCrayPBJrCaseyBRivera-PerezJ 1993 A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus. Hum Mol Genet 2 1561 1569
57. OienDBMoskovitzJ 2008 Substrates of the methionine sulfoxide reductase system and their physiological relevance. Curr Top Dev Biol 80 93 133
58. KuschelLHanselASchonherrRWeissbachHBrotN 1999 Molecular cloning and functional expression of a human peptide methionine sulfoxide reductase (hMsrA). FEBS Lett 456 17 21
59. MoskovitzJWeissbachHBrotN 1996 Cloning the expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins. Proc Natl Acad Sci U S A 93 2095 2099
60. MoskovitzJJenkinsNAGilbertDJCopelandNGJurskyF 1996 Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues. Proc Natl Acad Sci U S A 93 3205 3208
61. WeissbachHResnickLBrotN 2005 Methionine sulfoxide reductases: history and cellular role in protecting against oxidative damage. Biochim Biophys Acta 1703 203 212
62. RosensteinBJCuttingGR 1998 The diagnosis of cystic fibrosis: A consensus statement. J Pediatr 132 589 595
63. CuttingGRAntonarakisSEBuetowKHKaschLMRosensteinBJ 1989 Analysis of DNA polymorphism haplotypes linked to the cystic fibrosis locus in North American Black and Caucasian families supports the existence of multiple mutations of the cystic fibrosis gene. Am J Med Genet 44 307 318
64. WangXMyersASaikiRKCuttingGR 2002 Development and Evaluation of a PCR-based, Line Probe Assay for the Detection of 58 Alleles in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene. Clin Chem 48 1121 1123
65. GromanJDMeyerMEWilmottRWZeitlinPLCuttingGR 2002 Variant cystic fibrosis phenotypes in the absence of CFTR mutations. N Engl J Med 347 401 407
66. BarrettJCFryBMallerJDalyMJ 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 263 265
67. LangeCDeMeoDSilvermanEKWeissSTLairdNM 2004 PBAT: tools for family-based association studies. Am J Hum Genet 74 367 369
68. WilliamsRL 2000 A note on robust variance estimation for cluster-correlated data. Biometrics 56 645 646
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2012 Číslo 3
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- PIF4–Mediated Activation of Expression Integrates Temperature into the Auxin Pathway in Regulating Hypocotyl Growth
- Metabolic Profiling of a Mapping Population Exposes New Insights in the Regulation of Seed Metabolism and Seed, Fruit, and Plant Relations
- Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database
- Networks of Neuronal Genes Affected by Common and Rare Variants in Autism Spectrum Disorders